Hyperpolarized imaging for CNS lymphoma
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new type of imaging scan to see if it can better detect and monitor brain lymphoma. It may help doctors tailor treatment by seeing how the cancer responds early on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older with a life expectancy over 12 weeks.
- You must have a confirmed diagnosis of CNS lymphoma (a type of non-Hodgkin lymphoma in the brain or spinal cord).
- Your cancer must be measurable on an MRI scan with a contrast dye (gadolinium), with at least one spot of 1 cm or larger.
- You must have adequate kidney function (creatinine clearance greater than 50 ml/min) within 3 weeks before the imaging scan.
- You cannot have significant heart disease, like congestive heart failure (NYHA Grade II or worse).
- You must not be pregnant or breastfeeding, and if you could become pregnant, you need a negative pregnancy test and use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain biopsy and spinal fluid (lumbar puncture) tests to better diagnose and understand how well treatments may work for certain lymphomas in the brain. It may help doctors match the right therapy by studying what the disease looks like in the body and brain.
This trial studies how newly diagnosed primary central nervous system (brain) non-Hodgkin lymphoma responds to a specific type of radiation to the whole brain, and it also looks at changes in thinking, mood, and behavior. It may help doctors understand how this treatment affects day-to-day brain function.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
This trial tests a new method to improve the safety and accuracy of brain biopsies in people with a type of lymphoma that starts in the brain or spinal cord. It may help reduce complications and get more reliable results.
This trial tests a combination of radiation, immune-boosting drugs, and a targeted antibody for people newly diagnosed with primary central nervous system diffuse large B-cell lymphoma (a type of brain lymphoma). The goal is to see if this approach is safe and effective.
Hear when a new Primary CNS Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.